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Abstract: The hepatitis B virus-encoded X (HBX) protein plays important roles in Hepatocellular carcinoma (HCC). Previous studies
have demonstrated that HBX can induce alterations in the expression of numerous microRNAs (miRNAs) involved in the carcinogenesis
of various tumors. However, the global profile of liver miRNA changes induced by HBX has not been characterized. In this study, we
conducted a miRNA microarray analysis to investigate the influence of HBX on the expression of total miRNAs in liver in relation to
HCC. Comparative analysis of the data from human normal liver cells (L02) and human HCC cells (HepG2), with or without HBX,
identified 19 differentially expressed miRNAs, including 5 with known association to HBX. Target gene prediction for the aberrantly
expressed miRNAs identified a total of 304 potential target genes, involved in sundry pathways. Finally, pathway analysis of the HBXinduced miRNAs pathway showed that 5 of the total miRNAs formed an internetwork, suggesting that HBX might exert its pathological
effects on hepatic cells through functional synergy with miRNAs that regulated common pathways in liver cells. Therefore, this work
provides new insights into the mechanisms of HCC as well as potential diagnostic markers or therapeutic targets for use in clinical
management of HCC.
Key words: Hepatocarcinoma, HBX, miRNA, internetwork

1. Introduction
Hepatocellular carcinoma (HCC) remains one of the
most lethal malignant cancers worldwide, ranking
third among all the cancers for annual cancer mortality.
Chronic infection with hepatitis B virus (HBV) is a major
etiological risk for the development and progression of
HCC (Kew, 2010). The mechanisms underlying HBVinduced malignant transformation remain a topic of
intense research, and recent studies have revealed that
the hepatitis B virus-encoded X (HBX) protein, which is
essential for virus replication in vivo, plays an important
role in hepatocarcinogenesis (Chen et al., 1993).
HBX-induced HCC involves disruption of the signaling
pathways that control normal physiological functions in the
host cells (Tian et al., 2013). For instance, the HBX protein
can serve as a substrate of protein kinase B (Akt kinase)
(Srisuttee et al., 2012), the subsequent dysregulation of
which affects pathways that mediate cell survival and

oncogenic transformation (Vivanco and Sawyers, 2002).
Ectopic expression of HBX in human normal liver cells
(L02, stably transfected with HBX) leads to significantly
increased activity of the multifunctional Notch1 signaling
pathway and marked inhibition of apoptosis via the
caspase 9-caspase 3 signaling pathway (Sun et al., 2014).
Furthermore, HBX can interrupt the DNA repair process
through its regulation of the transactivating function of
p53 (Lee et al., 2005).
HBX can also induce aberrant expression of
microRNAs (miRNAs), and this infection-related process
has been shown to contribute to the pathogenesis of HCC
(Esteller, 2011; Xu et al., 2013; Wu et al., 2014). miRNAs can
function on either oncogenes or tumor suppressor genes
to mediate tumorigenesis (Wei et al., 2015). The presence
of HBX has been shown to be significantly associated with
alterations in the host miRNA proﬁle (Trang et al., 2008).
For example, it suppresses the expression of miRNA-
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148a, which results in the activation of AKT and of the
extracellular signal-regulated kinase signaling pathway,
ultimately leading to the activation of rapamycin and the
subsequent promotion of cancer cell proliferation and
metastasis, as shown in a mouse model (Xu et al., 2013).
Recent studies have demonstrated HBX inhibition of
the expression of miRNA-15b, which otherwise directly
targets the fucosyltransferase 2 enzyme and increases the
levels of the tumor-associated antigen Globo-H, ultimately
enhancing HCC cell proliferation (Wu et al., 2014). HBX
has also been shown to decrease the inhibitory effect of
miRNA-205 on carcinogenesis by down-regulating the
expression of miRNA-205 in the livers of HBX transgenic
mice (Zhang et al., 2013).
Although several reports have provided evidence for
a relationship between HBX, specific miRNAs, and target
genes (Esteller, 2011; Xu et al., 2013; Zhang et al., 2013;
Wu et al., 2014), the regulation of the global miRNA
profile in liver cells by HBX in relation to the development
and progression of HCC remains to be fully clarified.
Therefore, this study was designed to use microarray
analysis to investigate the alteration of miRNA profiles in
L02 and HepG2 cell lines that were transfected with HBXexpressing lentivirus, and to compare the results to those
from control L02 and HepG2 cells transfected with empty
lentivirus. The resulting set of differentially expressed
miRNAs were subject to target gene prediction and
pathway analysis. Finally, the internetwork of the HBXinduced miRNAs pathway was investigated to determine
whether HBX-induced mRNAs function in a synergistic
manner to support the pathogenesis of HCC.
2. Materials and methods
2.1. Cell lines
L02, HepG2, and HepG2.2.15, which was stably transfected
with 2.1-fold HBV genome DNA, were permissible to
HBV proliferation in cells (Sells et al., 1987) (all from the
Chinese Academy of Sciences). The cells were cultured in
a complete growth medium supplemented with 10% fetal
bovine serum in a humidified atmosphere with 5% CO2
and a temperature of 37 °C.
2.2. Tissues
All the patients underwent surgical resection of primary
HCC at the Institute of Hepatobiliary Surgery, Southwest
Hospital, Army Medical University (Third Military
Medical University). The HCC tissues and the adjacent
tissues were diagnosed by pathological identification
of the Department of Pathology, Southwest Hospital.
Patient-derived HCC tissues were obtained from patient
tumor specimens with informed consent according to the
protocols approved by the Institutional Review Board of
the Southwest Hospital, Army Medical University (Third
Military Medical University) (Chongqing, China).
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2.3. Lentivirus-mediated transfection of HBX
The cells were seeded into 24-well plates at a density of
1 × 104 cells/well. After 1 day of culture, the indicated
combinations and multiplicity of infection (MOI) ratios
of control (empty vector) or recombinant lentiviruses
expressing HBX and GFP were applied to the cells
according to the procedure reported by Chiang et al.
(2014). The virus-infected L02 and HepG2 cells were then
cultured in fresh 24-well plates for the indicated times,
with medium exchange every other day.
2.4. Total RNA extraction, qRT-PCR, and microarray
analyses
Total RNA was extracted from the cells and clinical
tissues (from Southwest Hospital, China) by using the
RNAiso reagent (TaKaRa, Japan). The miRNA microarray
was designed and detected by the Kangchen Company
(China). To validate the microarray findings, cDNA
synthesis was performed using a PrimeScript RT Reagent
Kit (TaKaRa) and the products were amplified by qPCR
with SYBR Premix Ex Taq II (TaKaRa), the appropriate
miRNA primers (TianGen Company, Beijing, China) and
the Stratagene Mx3000P real-time PCR system (Agilent
Technologies, CA, USA). The qPCR-detected expression
levels were normalized to those of the snRNA U6
endogenous control using the 2−∆∆Ct method.
2.5. Immunofluorescent and immunohistochemical
staining
For immunofluorescent staining, the cells were
simultaneously incubated with the primary rabbit
antimouse hepatitis B virus X antigen antibody (Abcam,
UK) and the secondary antirabbit IgG antibody (Abcam).
For immunohistochemical staining, endogenous
peroxidase activity was quenched by incubating the slide
with 0.6% hydrogen peroxide, after which the slides were
washed in phosphate-buffered saline and exposed to the
primary rabbit antimouse hepatitis B virus X antigen
antibody (Abcam). After the incubation, the slides were
washed and exposed to the secondary Alexa Fluor® 555
conjugated antirabbit IgG (Abcam). Then, the slides were
washed and exposed to the avidin–biotin complex for 30
min at room temperature. Also, the immunoreactions
were detected by use of the diaminiobenzidene reagent
(Sigma, China).
2.6. Target gene prediction
Microcosm
(http://www.ebi.ac.uk/enright-srv/
microcosm/), miRanda (http://microRNA.org), and
Targetscan (http://www.targetscan.org) programs, which
apply computational algorithms based on base-pairing
rules for miRNA binding to mRNA target sites, the location
of binding sequences within the 3’-UTR of the target,
and the conservation of target binding sequences within
the related genomes, respectively, were used to predict
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target genes for the differentially expressed miRNAs. The
genes identified by these software programs were taken
as target genes. The predicted genes were subjected to
pathway analysis (http://www.kegg.jp/) using the standard
enrichment computation method.
2.7. Gene pathway analysis
The functional analysis of the predicted genes was carried
out by mapping to KEGG pathways (http://www.kegg.jp/).
The EASE-score, the Fisher’s P-value, or the hypergeometric
P-value was calculated to determine the significance of the
pathway’s correlation with the conditions. The lower the
P-value, the more significant the pathway’s correlation; a
P-value cut-off of 0.05 was used.
2.8. miRNA-pathway analysis
Although 19 significantly differentially expressed miRNAs
were found, only when the overlap coefficient was ≥0.5
and the overlap numbers of the pathways of miRNAtargeted gene was >3, were the eligible miRNAs selected
for inclusion in the analysis of the miRNA-pathway
network. This strategy of miRNA selection was represented
by the following equation: given the sets X and Y, and
the cardinality operator ||where|X|equals the number
of elements within the set X, the overlap coefficient was
defined as overlap (X,Y)=|X∩Y|/min(|X|,|Y|) (Merico et
al., 2010). X remains to one collection of the target gene,
while Y remains to another collection of the target gene.
The miRNA-pathway network analysis was performed by
the CytoScape software.
2.9. Statistical analysis
Data generated from the microarray was imported to
Microsoft Excel. After normalizing the signal of each
miRNA by using global average normalization as described
by Bilban et al. (2002), the expression level of each miRNA
was calculated. Student’s t-test was performed to estimate
between-group differences. All the statistical analyses
were performed using the GraphPad Prism software 5.0.
Statistical significance was defined by a P-value of <0.05.
For each miRNA, the difference between HCC and normal
liver cells was considered significant if the fold-change was
>2 or <0.5 and the P-value was <0.05.
3. Results
3.1. HBX-induced aberrant miRNAs in normal liver cells
and HCC cells
To define the global profile of HBX-induced alterations in
miRNA of liver cells in relation to HCC, we first established
HBX-overexpression cell lines by infecting L02 and
HepG2 cells with empty lentivirus vector or recombinant
lentivirus, respectively. The qPCR analysis indicated that
HBX mRNA was elevated thousands of times higher in
the L02 cells transfected with HBX-expressing lentivirus,
as compared with the L02 cells transfected with the empty

lentivirus (Figure 1A). The qRT-PCR results were similar
for the HepG2 cells, although the HBX mRNA expression
level in the HepG2-HBX cells was lower than that in
the HepG2.2.15 cells (Sells et al., 1987) (Figure 1A). The
ectopic expression of the HBX protein, from the HBX
gene encoded by the recombinant lentivirus vector, was
verified in the transfected cells by immunohistochemical
staining (Figure 1B). Immunofluorescent staining
confirmed that the HBX protein was expressed in both
nuclei and the cytoplasm, consistent with previous reports
(Majano et al., 2001; Shirakata and Koike, 2003). The
HepG2 cells that were transfected with empty lentivirus
(lacking the HBX gene, but encoding the GFP gene) did
not express any HBX protein that was detectable by either
immunohistochemistry or immunofluorescence, although
the GFP protein was appropriately expressed (Figure 1C).
Upon the microarray analysis of these four cell lines
(L02-empty lentivirus, L02-recombinant lentivirus (L02HBX), HepG2-empty lentivirus, HepG2-recombinant
lentivirus (HepG2-HBX)), miRNAs with ≥2-fold-change
differential expression were selected as the candidate
target miRNAs of HBX. The up- and downregulated
candidate target miRNAs were presented in Figure 2, and
were assessed to determine the key HBX-induced miRNAs
that may play pivotal roles in both normal liver and HCC
cells. The comparison of the differential miRNA profiles
of the L02-HBX cells and the HepG2-HBX cells showed
15 miRNAs that were simultaneously decreased (2- to 36fold) and 4 miRNAs that were simultaneously increased
(2.0- to 10.6-fold) in these cells (Table).
3.2. Validation of candidate miRNAs induced by HBX
In order to validate the microarray results, we selected
three miRNAs for qPCR verification. The results showed
that the expression levels of miRNA-21, miRNA-211, and
miRNA-125b—among the 15 downregulated candidate
miRNAs (Table)—were decreased about 0.5-, 0.46-, and
0.378-fold-change, respectively, as compared to the vectors
alone. These results were consistent with the microarray
results (Figure 3A). Furthermore, the expression levels
of these three miRNAs in surgery specimens from 10
HCC patients with HBV infection were also significantly
reduced compared to the levels detected in paired adjacent
nontumor tissues (Figure 3B); in addition, the level of HBX
mRNA was significantly higher in the tumor tissues than
the adjacent nontumor tissues (Figure 3C). These in vitro
and in vivo results indicated that miRNA-21, miRNA-211,
and miRNA-125b were downregulated in the presence of
HBX, thus supporting the accuracy of the data generated
from the microarray (Table).
3.3. Candidate target genes of miRNAs induced by HBX
Prediction analysis by three different computational
algorithms identified 38,187, 9684, and 5459 target genes,
respectively, as targets of the total set of HBX-altered
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Figure 1. Establishment of HBX expressing HepG2 and L02 cell lines. A: HBX mRNA level in L02 and HepG2 cells transfected
with empty lentivirus (C) or recombinant lentivirus (HBX) was detected by qRT-PCR. B: HBX protein expression was detected
by immunohistochemical staining of untransfected HepG2.2.15 and HepG2 cells, HepG2-HBX cells and HepG2-C cells. C:
Immunofluorescent analysis of HBX protein showed localization of the ectopically expressed HBX from the recombinant lentivirus
and lack of HBX in the cells transfected with empty vector. *P < 0.05, **P < 0.001; ns, not significant.

miRNAs. A total of 304 target genes overlapped among
these three algorithms, as shown by the Venn diagram
(Figure 4). The overlapping target genes included some
important genes that have been previously verified by
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other studies in the literature, including B-cell lyphoma-3
(BCL3) (Ahlqvist et al., 2013) and cytidine deaminase
(CDA) (Zauri et al., 2015). The overlapping target genes
also included many genes that have yet to be verified;
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Figure 2. Differential expression of HBX-induced miRNAs in normal liver and HCC cells. Scatter plots of up- and downregulated
miRNAs in control (x-axis) and HBX over-expressing (y-axis) cells. Each point in the figure represents a single miRNA. The red points
represent upregulated miRNAs with a ratio of >2. The black points represent equally-expressed miRNAs with a ratio of ≥1/2 and ≤2. The
blue points represent downregulated miRNAs with a ratio of <1/2.

Figure 3. Validation of miRNA expression by qRT-PCR. A: The relative expression of miRNA-21, miRNA-211, and miRNA-125b in L02
and HepG2 cells transfected with empty lentivirus (C) or recombinant lentivirus (HBX). B: The relative expression level of miRNA-21,
miRNA-211, and miRNA-125b in HBV-infected HCC samples (Ca) and the adjacent tissues (Aj). C: The relative HBX mRNA expression
in HBV-infected HCC samples and the adjacent tissues. *P < 0.05; **P < 0.001.
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Table. Fold-changes and chromosome locations of miRNAs showing differential expression in both HepG2HBX and L02-HBX cells.
Fold-change
Name

HepG2-HBX vs
HepG2-C

L02-HBX vs
L02-C

Location

hsa-miR-4436b

10.57

2.010521666

Chr2: 110086433-110086523

hsa-miR-5584

2.521

2.287049727

Chr1: 44545493-44545552

hsa-miR-663a

2.09

4.009075941

Chr20: 26208186-26208278

hsa-miR-4776

2.00

3.958031355

Chr2: 212926257-212926336

hsa-miR-4796

0.496919918

0.473770783

Chr3: 114743445-114743525

hsa-miR-211

0.470588235

0.429258291

Chr15: 31065095-31065116

hsa-miR-25

0.439732143

0.059836954

Chr7: 100093560-100093643

hsa-miR-4489

0.428776978

0.027965903

Chr11: 65649192-65649253

hsa-miR-4447

0.411417323

0.432633765

Chr3: 116850277-116850367

hsa-miR-622

0.406779661

0.487823306

Chr13: 90231182-90231277

hsa-miR-4283

0.327731092

0.31295177

Chr7: 56955785-56955864

hsa-miR-132

0.322946176

0.359399797

Chr17: 2049908-2050008

hsa-miR-219-2

0.3125

0.373606984

Chr9: 128392618-128392714

hsa-miR-21

0.310725552

0.408140061

Chr17: 59841266-59841337

hsa-miR-4638

0.300433839

0.328614016

Chr5: 181222566-181222633

hsa-miR-1909

0.294372294

0.472577776

Chr19: 1816159-1816238

hsa-miR-125b-1

0.244444444

0.163997579

Chr11:122099757-122099844

hsa-miR-632

0.227272727

0.302395535

Chr17: 32350109-32350202

hsa-miR-26a-2

0.125348189

0.344113776

Chr12: 57824609-57824692

Upregulated

Downregulated

therefore, we selected two candidate target genes—
BCL2L10 and ARHGAP10—to verify their expression in
vitro and in vivo.
BCL2L10 was identified as a potential target of miRNA125b, and ARHGAP10 was identified as a potential target
of miRNA-21 and miRNA-211. According to previous
reports, BCL2L10 can induce cell apoptosis through a
mitochondrial signaling pathway under conditions of
gastric cancer (Xu et al., 2011) and ARHGAP10 can
contribute to the adherens junction (Sousa et al., 2005).
By using the qRT-PCR assay, we found that the marked
decrease of the three miRNAs cited above as observed
in HepG2-HBX and L02-HBX cell lines (Figure 3)
was accompanied by significant up-regulation of both
BCL2L10 and ARHGAP10 (Figure 4B and 4C). In vivo
analysis of liver tissues confirmed this finding, with the
mRNA expression level of BCL2L10 and ARHGAP10
being shown as significantly increased in HBV-infected
liver tissues (Figure 4D).
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3.4 Analysis of HBX-induced miRNA target genes according to KEGG pathways
Because signaling pathways play key roles in many
biological and pathological events, we performed
enrichment analysis of the KEGG pathways for each
of the HBX-induced miRNA target genes. The top 10
enriched KEGG pathways for the genes related to the
upregulated miRNAs were involved in chronic myeloid
leukemia, nonsmall cell lung cancer, glioma, bladder
cancer, long-term potentiation, the MAPK signaling
pathway, endometrial cancer, the ErbB signaling pathway,
acute myeloid leukemia, and the mTOR signaling pathway
(Figure 5A). For the genes related to the downregulated
miRNAs, the top 10 enriched KEGG pathways for
the target genes were involved in the neurotrophin
signaling pathway, pathways in cancer, transcriptional
misregulation in cancer, the MAPK signaling pathway,
axon guidance, the FoxO signaling pathway, proteoglycans
in cancer, the Hippo signaling pathway, focal adhesion,
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Figure 4. Prediction and validation of target genes of HBX-induced miRNAs. A: Summary of the predicted miRNA target genes
identified by three algorithms: TargetScan, miRanda, and Microcosom. The numbers in the Venn diagram indicate the target genes
predicted by each algorithm and the overlap among them. B, C: The relative mRNA expression of BCL2L10 and ARHGAP10 genes,
respectively, in L02 and HepG2 cells transfected with empty lentivirus (C) or recombinant lentivirus (HBX) determined by qRT-PCR.
D: The relative mRNA level of HBX in HBV-infected HCC samples (Ca) and the paired adjacent tissues (Aj) determined by qRT-PCR.
*P < 0.05; **P < 0.001.

and cytokine-cytokine receptor interaction (Figure 5B).
Among these enrichment pathways, most were cancerrelated (e.g., acute/chronic myeloid leukemia, bladder
cancer, endometrial cancer, and proteoglycans in cancer),
suggesting that these pathways might represent potential
host mechanisms that were manipulated by the virusencoded HBX through its regulation of host miRNAs and
leading to HCC.
3.5 Pathways-based miRNAs internetwork induced by
HBX
In order to directly show the roles of differentially
expressed miRNAs on pathways, we generated a network
between the miRNAs and potential pathways by using
the CytoScape software. The miRNAs were selected only

when the overlap-coefficient was ≥0.5 and the overlap
numbers of the pathways of miRNA-targeted gene were
≥3; the eligible miRNAs were thus included to make up
the pathways-based miRNAs internetwork. A total of 5
miRNAs were identified as interacting with others and
found to mediate at least 3 common pathways (Figure
6). Among these, only miRNA-663a, one of the total four
upregulated miRNAs fitting the criteria for this analysis
(overlap-coefficient of ≥0.5 and overlap numbers of the
pathways of miRNA-targeted gene of ≥3), formed an
internetwork with the other miRNAs. In addition, among
the 15 downregulated miRNAs that fit the criteria for this
analysis, only miRNA-21, miRNA-211, miRNA-25, and
miRNA-622 were involved in the network (Figure 6).
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Figure 5. KEGG pathway analysis of target genes of the HBX-induced differentially
expressed miRNAs. A, B: The top 10 enriched pathways for the upregulated and
downregulated miRNAs, respectively.

4. Discussion
In the present study, we performed microarray to
investigate the HBX-induced differential expression
pattern of miRNAs in human liver cells in relation to
HCC. We identified a total of 19 miRNAs that showed
significant changes in expression following ectopic
HBX induction. Five of the 19 miRNAs (miRNA-132,
miRNA-219, miRNA-125b, miRNA-26a, and miRNA-21)
had been previously demonstrated to be associated with
HCC (Wei et al., 2013; Zhou et al., 2014; Song et al., 2015;
Zhou et al., 2015). Based on the KEGG pathway analysis,
we found that the target genes of these miRNAs were
closely associated with tumor-related biological processes
(Figure 5). We also demonstrated in this study that HBX
might exert pathological effects through miRNAs that
target common pathways in hepatic cells (Figure 5).
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Some of the HBX-induced miRNAs and their target
genes predicted in the current study were mapped for
their putative cooperation with each other in liver cells. In
particular, 5 of the miRNAs—miRNA-663a, miRNA-21,
miRNA-211, miRNA-25, and miRNA-622—had the
potential to regulate common pathways in conjunction
with the others, which were involved in several cancerrelated pathways including colorectal cancer, gastric
cancer, and HCC ( Guo et al., 2011; Fang et al., 2015; Song
et al., 2015; Xu et al., 2015) (Figure 6).
Therefore, this study provides new potential markers of
clinical diagnosis and/or therapeutic targets of HCC.
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Figure 6. HBX-induced miRNAs internetwork analysis. The red square nodes represent the eligible miRNAs; the green circular nodes
represent the specific pathways (function terms). The arrows indicate the direction of relationships.
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